Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment

Cancer cells have adapted to rapid tumor growth and evade immune attack by reprogramming their metabolic pathways. Glutamine is an important nitrogen resource for synthesizing amino acids and nucleotides and an important carbon source in the tricarboxylic acid (TCA) cycle and lipid biosynthesis path...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxin Fan (Author), Han Xue (Author), Zhimin Li (Author), Mingge Huo (Author), Hongxia Gao (Author), Xingang Guan (Author)
Format: Book
Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2e3e5730f7b04f3f8d86effd58b3b5a1
042 |a dc 
100 1 0 |a Yuxin Fan  |e author 
700 1 0 |a Yuxin Fan  |e author 
700 1 0 |a Han Xue  |e author 
700 1 0 |a Han Xue  |e author 
700 1 0 |a Zhimin Li  |e author 
700 1 0 |a Zhimin Li  |e author 
700 1 0 |a Mingge Huo  |e author 
700 1 0 |a Mingge Huo  |e author 
700 1 0 |a Hongxia Gao  |e author 
700 1 0 |a Xingang Guan  |e author 
245 0 0 |a Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment 
260 |b Frontiers Media S.A.,   |c 2024-03-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1345522 
520 |a Cancer cells have adapted to rapid tumor growth and evade immune attack by reprogramming their metabolic pathways. Glutamine is an important nitrogen resource for synthesizing amino acids and nucleotides and an important carbon source in the tricarboxylic acid (TCA) cycle and lipid biosynthesis pathway. In this review, we summarize the significant role of glutamine metabolism in tumor development and highlight the vulnerabilities of targeting glutamine metabolism for effective therapy. In particular, we review the reported drugs targeting glutaminase and glutamine uptake for efficient cancer treatment. Moreover, we discuss the current clinical test about targeting glutamine metabolism and the prospective direction of drug development. 
546 |a EN 
690 |a glutamine 
690 |a glutamine metabolism 
690 |a glutamine uptake 
690 |a cancer therapy 
690 |a combination therapy 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1345522/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/2e3e5730f7b04f3f8d86effd58b3b5a1  |z Connect to this object online.